Skip to main content
SpringerLink
Log in

Reduktion des Septikämie risikos bei der Anwendung von Thrombozytenkonzentraten

Bei der 66. Sitzung des Arbeitskreises Blut am 9. Juni 2008 wurde folgende Ergänzung zum Votum 38 (V 38) verabschiedet:

  • Bekanntmachung
  • Mitteilungen des Arbeitskreises Blut des Bundesministeriums für Gesundheit
  • Published:
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Ramírez-Arcos S, Jenkins C, Dion J, et al. (2007) Canadian experience with detection of bacterial contamination in apheresis platelets. Transfusion 47:421–429

    Article  PubMed  Google Scholar 

  2. te Boekhorst PAW, Beckers EAM, Vos MC, et al. (2005) Clinical significance of bacteriologic screening in platelet concentrates. Transfusion 45:514–519

    Article  PubMed  CAS  Google Scholar 

  3. Larsen CP, Ezligini F, Hermansen NO, Kjeldsen-Kragh J (2005) Six years’ experience of using the BacT/ALERT system to screen all platelet concentrates, and additional testing of outdated platelet concentrates to estimate the frequency of false-negative results. Vox Sang 88:93–97

    Article  PubMed  CAS  Google Scholar 

  4. De Korte D, Curvers J, de Kort WLAM, et al. (2006) Effects of skin disinfection method, deviation bag, and bacterial screening on clinical safety of platelet transfusions in the Netherlands. Transfusion 46:476–485

    Article  PubMed  Google Scholar 

  5. Kleinmann DH, Kamel HAT, Harpool DR, et al. (2006) Two-year experience with aerobic culturing of apheresis and whole blood-derived platelets. Transfusion 46:1787–1794

    Article  Google Scholar 

  6. Eder AF, Kennedy JM, Dy BA, et al. (2007) Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004–2006). Transfusion 47:1134–1142

    Article  PubMed  Google Scholar 

  7. Schrezenmeier H, Walther-Wenke G, Müller TH, et al. (2007) Bacterial contamination of platelet concentrates: results of a prospective multicenter study comparing pooled whole blood-derived platelets and apheresis platelets. Transfusion 47:644–652

    Article  PubMed  Google Scholar 

  8. Montag T (2006) Möglichkeiten und Grenzen des Screenings von Thrombozyten-Konzentraten auf bakterielle Kontamination. J Lab Med 30(2):60–65

    Google Scholar 

  9. Knutson F, Alfonso R, Dupuis K, et al. (2000) Photochemical inactivation of bacteria and HIV in buffycoat derived platelet concentrates under conditions that preserve in vitro platelet function. Vox Sang 78:208–216

    Article  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reduktion des Septikämie risikos bei der Anwendung von Thrombozytenkonzentraten. Bundesgesundheitsbl. 51, 1485–1487 (2008). https://doi.org/10.1007/s00103-008-0724-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00103-008-0724-1

Search

Navigation